KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma [Corrigendum]
Sun Z, Zhou R, Dai J, et al. Int J Gen Med. 2023;16:4849–4862. The authors have advised that the correspondence section on page 4849 is incorrect. The correct correspondence is as follows. Correspondence: Yao Xu, Institute of Biology and Medicine, College of Life Science and Health, Wuhan...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-krt19-is-a-promising-prognostic-biomarker-and-associates-w-peer-reviewed-fulltext-article-IJGM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|